128 related articles for article (PubMed ID: 9724573)
1. Effect of cilastatin on renal handling of vancomycin in rats.
Kusama M; Yamamoto K; Yamada H; Kotaki H; Sato H; Iga T
J Pharm Sci; 1998 Sep; 87(9):1173-6. PubMed ID: 9724573
[TBL] [Abstract][Full Text] [Related]
2. [Nephrotoxicity and drug interaction of vancomycin].
Toyoguchi T; Nakagawa Y; Watanabe H
Nihon Yakurigaku Zasshi; 1996 Feb; 107(2):53-66. PubMed ID: 8721008
[TBL] [Abstract][Full Text] [Related]
3. Effects of fosfomycin and imipenem/cilastatin on nephrotoxicity and renal excretion of vancomycin in rats.
Nakamura T; Hashimoto Y; Kokuryo T; Inui KI
Pharm Res; 1998 May; 15(5):734-8. PubMed ID: 9619782
[TBL] [Abstract][Full Text] [Related]
4. Nephrotoxicity of vancomycin and drug interaction study with cilastatin in rabbits.
Toyoguchi T; Takahashi S; Hosoya J; Nakagawa Y; Watanabe H
Antimicrob Agents Chemother; 1997 Sep; 41(9):1985-90. PubMed ID: 9303398
[TBL] [Abstract][Full Text] [Related]
5. Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
Nakamura T; Kokuryo T; Hashimoto Y; Inui KI
J Pharm Pharmacol; 1999 Feb; 51(2):227-32. PubMed ID: 10217324
[TBL] [Abstract][Full Text] [Related]
6. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats.
Humanes B; Lazaro A; Camano S; Moreno-Gordaliza E; Lazaro JA; Blanco-Codesido M; Lara JM; Ortiz A; Gomez-Gomez MM; Martín-Vasallo P; Tejedor A
Kidney Int; 2012 Sep; 82(6):652-63. PubMed ID: 22718191
[TBL] [Abstract][Full Text] [Related]
7. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.
Oktem F; Arslan MK; Ozguner F; Candir O; Yilmaz HR; Ciris M; Uz E
Toxicology; 2005 Nov; 215(3):227-33. PubMed ID: 16112787
[TBL] [Abstract][Full Text] [Related]
8. Interaction between levofloxacin and vancomycin in rats--study of serum and organ levels.
Mori H; Nakajima T; Nakayama A; Yamori M; Izushi F; Gomita Y
Chemotherapy; 1998; 44(3):181-9. PubMed ID: 9612608
[TBL] [Abstract][Full Text] [Related]
9. Role of the poly(ADP-ribose)polymerase activity in vancomycin-induced renal injury.
Dalaklioglu S; Tekcan M; Gungor NE; Celik-Ozenci C; Aksoy NH; Baykal A; Tasatargil A
Toxicol Lett; 2010 Feb; 192(2):91-6. PubMed ID: 19833176
[TBL] [Abstract][Full Text] [Related]
10. [Nephrotoxicity and drug interaction of vancomycin (2)].
Toyoguchi T; Nakagawa Y
Nihon Yakurigaku Zasshi; 1996 May; 107(5):225-35. PubMed ID: 8690304
[TBL] [Abstract][Full Text] [Related]
11. Novel evidence suggesting an anti-oxidant property for erythropoietin on vancomycin-induced nephrotoxicity in a rat model.
Cetin H; Olgar S; Oktem F; Ciris M; Uz E; Aslan C; Ozguner F
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1181-5. PubMed ID: 17880374
[TBL] [Abstract][Full Text] [Related]
12. Difference in nephrotoxicity of vancomycin administered once daily and twice daily in rats.
Konishi H; Morita Y; Mizumura M; Iga I; Nagai K
J Chemother; 2013 Oct; 25(5):273-8. PubMed ID: 24070134
[TBL] [Abstract][Full Text] [Related]
13. In-vivo clearance study of vancomycin in rats.
Nakamura T; Takano M; Yasuhara M; Inui K
J Pharm Pharmacol; 1996 Nov; 48(11):1197-200. PubMed ID: 8961172
[TBL] [Abstract][Full Text] [Related]
14. Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats.
Nishino Y; Takemura S; Minamiyama Y; Hirohashi K; Ogino T; Inoue M; Okada S; Kinoshita H
Free Radic Res; 2003 Apr; 37(4):373-9. PubMed ID: 12747731
[TBL] [Abstract][Full Text] [Related]
15. Decreased renal accumulation and toxicity of a new VCM formulation in rats with chronic renal failure.
Hodoshima N; Masuda S; Inui K
Drug Metab Pharmacokinet; 2007 Dec; 22(6):419-27. PubMed ID: 18159129
[TBL] [Abstract][Full Text] [Related]
16. Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity.
Humanes B; Jado JC; Camaño S; López-Parra V; Torres AM; Álvarez-Sala LA; Cercenado E; Tejedor A; Lázaro A
Biomed Res Int; 2015; 2015():704382. PubMed ID: 26504822
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of inactive ingredients against nephrotoxicity of vancomycin hydrochloride in rats.
Hodoshima N; Nakano Y; Izumi M; Mitomi N; Nakamura Y; Aoki M; Gyobu A; Shibasaki S; Kurosawa T
Drug Metab Pharmacokinet; 2004 Feb; 19(1):68-75. PubMed ID: 15499172
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-induced renal inflammation is ameliorated by cilastatin nephroprotection.
Humanes B; Camaño S; Lara JM; Sabbisetti V; González-Nicolás MÁ; Bonventre JV; Tejedor A; Lázaro A
Nephrol Dial Transplant; 2017 Oct; 32(10):1645-1655. PubMed ID: 28340076
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of tobramycin binding to rat renal brush border membrane by vancomycin.
Yano Y; Hiraoka A; Oguma T
J Pharmacol Exp Ther; 1995 Aug; 274(2):695-9. PubMed ID: 7636730
[TBL] [Abstract][Full Text] [Related]
20. Cilastatin-insulin interaction in the rat.
Tompkins GC; Brunner LJ; Luke DR
Drug Metab Dispos; 1989; 17(1):54-7. PubMed ID: 2566470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
